-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
- AEON Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $153M.
- AEON Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$48.4M, a 2402% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)